Provider review
Intimate Rose review
A pelvic-health brand that added a GLP-1 line, and promises the price will not change.
It states in writing that there are no memberships, no monthly fees and no price changes — a durability commitment almost nothing else here makes. The figure is still a floor.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Intimate Rose
From $169/mo, with no price changes promised
FDA warning letter · Intimate Rose · September 2025 · addressed to Intimate Rose. Details in our review.
- Vs median
- Exactly the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This began as a pelvic-health company — kegel weights, pelvic floor devices, supplements sold to clinicians and patients — and the GLP-1 line is an addition rather than the reason the business exists. Worth knowing up front, because it sets expectations about what the clinical relationship looks like. What the page does unusually well deserves naming: alongside the price it states there are no memberships, no monthly fees and no price changes. That last clause is a commitment barely anything else reviewed on this site makes. A great many sellers here run a figure marked limited-time with no standing rate published anywhere, or simply reserve the right to move it without saying so; putting the opposite in writing next to the number is the kind of thing that ought to be ordinary and is not. The limits are the familiar ones. It remains an as-low-as figure, so a reader learns the floor and never the ceiling, and no dose is attached to it — which for somebody whose entire question is what a small dose costs leaves the answer one intake away.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a written commitment that the price will not move once you start.
- You want no membership and no monthly fee sitting underneath the medication price.
- You prefer an established company with a long clinical products history behind it.
Look elsewhere if
- You need a ceiling. The published figure is a floor with no upper bound beside it.
- You are pricing a specific dose. None is attached to the figure.
- You want a clinic whose core business is metabolic care.
What it actually costs
Price as published
Treatment plans "as low as $169/month", with the site stating "no memberships, no monthly fees, no price changes" · ★ that last clause is a commitment almost nothing else here makes: most sellers reviewed on this site either run a limited-time headline with no standing rate or reserve the right to move the figure without saying so, and this one puts the promise in writing beside the price · it is still an "as low as", so the floor is published and the ceiling is not, and no dose sits behind the figure · the GLP-1 line is an addition to a pelvic-health and continence business — kegel weights, pelvic wands, supplements — rather than the company's original trade, and the two sit on the same storefront
- Vs median
- Exactly the $169 median
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★ The site commits in writing to no memberships, no monthly fees and no price changes, which almost nothing else here does. But the single figure is an "as low as" attached to no molecule and no dose, so nothing is readable per molecule before intake. No low-dose product is offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- States in writing that there are no memberships, no monthly fees and no price changes.
- The entry figure is visible before any intake and is mid-range for the field.
- An established company with a long-standing clinical products business behind it.
Pharmacy, labs and oversight
Intimate Rose dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Intimate Rose publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to Intimate Rose in September 2025. It is addressed to Intimate Rose — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Intimate Rose is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
This began as a pelvic-health company — kegel weights, pelvic floor devices, supplements sold to clinicians and patients — and the GLP-1 line is an addition to it rather than the reason the business exists. That is worth knowing up front, because it sets expectations about what the clinical relationship looks like. What the page does well is unusual enough to name: alongside the price it states there are no memberships, no monthly fees and no price changes. The last of those is a commitment barely anything else on this site makes. A great many sellers here advertise a figure marked limited-time with no standing rate published, or quietly reserve the ability to move it; putting the opposite in writing beside the number is the kind of thing that ought to be ordinary and is not. The limits are the familiar ones. It is still an "as low as", so a reader learns the floor and not the ceiling, and no dose is attached to the figure — which for someone whose whole question is what a small dose costs leaves the answer one intake away.
The honest cons
The figure is an "as low as" with no ceiling published and no dose behind it.
- GLP-1 care is an addition to a pelvic-health business rather than its core trade.
- No compounding pharmacy is named.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Intimate Rose is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#196 of 373
Ordered with the companies that pay us first, and Intimate Rose is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- What the evidence actually shows
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.